As part of the Mayo Clinic RNA Discoveries and Therapeutics Conference 2026, abstract submissions are open. Abstracts will be evaluated for oral and poster display at the course. Abstract topics may include but are not limited to RNA biology; applications of RNA therapeutics in neurologic, metabolic, rare diseases, or other conditions; computational design; and innovations in RNA therapeutic deliveries. Abstracts should be 300 words or less and may include one figure or table.Abstract Eligibility: Original abstracts that either have or have not been presented at other meetings will be considered. Previously published abstracts should be sufficiently modified.Specific topics of interest: RNA biology; applications of RNA therapeutics in neurologic, metabolic, rare diseases, or other conditions; computational design; and innovations in RNA therapeutic deliveriesSubmission CriteriaCreate a profile if you have not done so already, then log into your accountComplete and submit abstract form no later than October 19thAbstracts are limited to 300 wordsComplete the form belowNotification of Results: All primary authors will be notified by October 28th if their submission has been selected for presentation. Details regarding presentation will follow.Presentation of Abstracts: Abstracts chosen for presentation will be uploaded to the conference website and presented during the live & livestream Mayo Clinic RNA Discoveries and Therapeutics Conference on December 2nd-4th, 2026. Scholarship & Registration Requirements: The primary author selected for an oral presentation at the conference will get free registration to attend the conference. All travel and lodging expenses are the sole responsibility of the author.Abstracts will be evaluated based on quality of the abstract, relevance to the conference theme, and teaching method. Abstract Title * Primary Presenter's Name * Primary Presenter's Institution * Primary Presenter's Email * Primary Presenter's Cell Phone Number Primary Presenter Bio * Please provide a brief bio sketch that will be included in the conference workbook. The bio sketch is a summary of your professional and educational accomplishments. Please highlight your expertise as it relates to your presentation. How many co-author will you be having? * No more than 15 co-authors Co-Author #1 Co-Author Name Co-Author Email Co-Author #2 Co-Author Name Co-Author Email Co-Author #3 Co-Author Name Co-Author Email Co-Author #4 Co-Author Name Co-Author Email Co-Author #5 Co-Author Name Co-Author Email Co-Author #6 Co-Author Name Co-Author Email Co-Author #7 Co-Author Name Co-Author Email Co-Author #8 Co-Author Name Co-Author Email Co-Author #9 Co-Author Name Co-Author Email Co-Author #10 Co-Author Name Co-Author Email Co-Author #11 Co-Author Name Co-Author Email Co-Author #12 Co-Author Name Co-Author Email Co-Author #13 Co-Author Name Co-Author Email Co-Author #14 Co-Author Name Co-Author Email Co-Author #15 Co-Author Name Co-Author Email Abstract (300 words maximum) * Learning Objectives * Include two to three learning objectives for your presentation. References * Copyright Material * Applicants must attest to the following : The primary presenter attests there are no copyrighted figures, images, or content submitted as part of the abstract. Agreement and Submission * The primary presenter must agree and confirm the following prior to submission and attest this represents all presenters: If selected, I grant Mayo Clinic all the rights and permissions necessary to record, archive, and post this presentation to be viewable by registered conference attendees. I understand that I retain the rights I currently have to reuse and expand upon the abstract submitted. If I am an employee or student of Mayo Clinic, I understand copyright is held by Mayo Foundation for Medical Education and Research and that I must request permission to reuse the content. Attendance Agreement * The primary presenter must agree and confirm the following prior to submission and attest this represents all presenters: If selected one author of this submission will attend the course. Disclosure of Financial Relationship * Do you or your co-presenter(s) have (or have had within the past 24 months) a financial relationship with a proprietary entity producing, marketing, re-selling, or distributing health care goods or services, consumed by, or used on patients? Exemption includes non-profit or government organizations. No Yes Financial Relationships * I (and/or my co-presenters) do have a relevant financial relationship. Check all boxes that apply. Consultant Speaker's Bureau Grant/Research Support Stock Shareholder Honoraria Full-time/Part-time Employee Other Consultant Financial Relationship Explanation * Speaker's Bureau Financial Relationship Explanation * Grant/Research Support Financial Relationship Explanation * Stock Shareholder Financial Relationship Explanation * Honoraria Financial Relationship Explanation * Full-time/Part-time Employee Financial Relationship Explanation * Other Financial Relationship Explanation * Disclosure of Off-Label and/or Investigational Uses * If, at any time, during my education activity, I discuss an off-label/investigation (unapproved) use of commercial product/device, I understand that I must provide disclosure of that intent. No, I do not intend to discuss an off-label/investigative use of a commercial product/device. Yes, I do intend to discuss off-label/investigative uses of a commercial product/device. Off-Label and/or Investigational Uses * Manufacturer/Provider and Product/Device Other Manufacturer/Provider Name * Product/Device Name * Other - please explain * Additional Information you would like to share? Leave this field blank
